Top Vaccines companies in Australia by Price to Sales Ratio (P/S)
This ranking features the top 1 Vaccines companies in Australia ranked by Price to Sales Ratio (P/S), averaging a Price to Sales Ratio (P/S) of 5.64, for February 06, 2025.
Australia
Vaccines
Price to Sales Ratio (P/S)
# |
Name |
Price to Sales Ratio (P/S) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
5.64 |
Feb. 5, 2025 | USD 169.95 | -0.56% |
|
Australia |
Frequently Asked Questions
-
Which Vaccines company in Australia has the highest Price to Sales Ratio (P/S) ?
The Vaccines company in Australia with the highest Price to Sales Ratio (P/S) is CSL Limited (ASX: CSL.AX) at 5.64.
-
Which Vaccines company in Australia has the lowest Price to Sales Ratio (P/S) ?
The Vaccines company in Australia with the lowest Price to Sales Ratio (P/S) is CSL Limited (ASX: CSL.AX) at 5.64.
-
What are the top 10 Vaccines companies in Australia by Price to Sales Ratio (P/S) ?
The top 10 Vaccines companies in Australia by Price to Sales Ratio (P/S) are and CSL Limited.
-
What are the bottom 10 Vaccines companies in Australia by Price to Sales Ratio (P/S) ?
The bottom 10 Vaccines companies in Australia by Price to Sales Ratio (P/S) are and CSL Limited.
